NCT07176767 The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents
| NCT ID | NCT07176767 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lena Xiao |
| Condition | Sleep Apnea, Obstructive |
| Study Type | OBSERVATIONAL |
| Enrollment | 82 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 82 participants in total. It began in 2025-06-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.
Eligibility Criteria
Inclusion Criteria: 1. Children aged 8-18 years old 2. Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG) 3. Newly prescribed PAP therapy Exclusion Criteria: 1\) Developmental disability precluding ability to answer questionnaires
Contact & Investigator
Lena J Xiao, MD, MSc
PRINCIPAL INVESTIGATOR
Provincial Health Services Authority British Columbia
Frequently Asked Questions
Who can join the NCT07176767 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Sleep Apnea, Obstructive. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07176767 currently recruiting?
Yes, NCT07176767 is actively recruiting participants. Contact the research team at lena.xiao@cw.bc.ca for enrollment information.
Where is the NCT07176767 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT07176767 clinical trial?
NCT07176767 is sponsored by Lena Xiao. The principal investigator is Lena J Xiao, MD, MSc at Provincial Health Services Authority British Columbia. The trial plans to enroll 82 participants.